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Purpose: Symptomatic cerebrovascular disease is more common in patients who have 
diabetes mellitus than in the nondiabetic population, even when matched for associated 
risk factors. Although the safety and efficacy of carotid endarterectomy has been estab- 
lished by NASCET and ACAS, several small studies have noted an increased rate of 
perioperative neurologic morbidity in patients with diabetes. 
Methoas: Data for all patients who underwent carotid endartereetomy at a single institu- 
tion from Jan. 1990 to Dec. 1995 were prospectively entered into a computerized 
vascular registry and form the basis of this report. 
Results: Of 732 carotid endarterectomy procedures performed, 284 (39%) were per- 
formed in patients who had diabetes mellitus. Patients with diabetes and without 
diabetes were matched for clinical presentation (diabetic patients, 45% asymptomatic; 
nondiabetic patients, 43%) and internal carotid artery percent stenosis (86.6% + 10.6% vs 
86.4% --4- 10.6%). Patients with diabetes were younger at presentation than patients 
without (68.8 -+ 8.5 years vs 70.9 -+ 8.5 years; p < 0.005) and were more likely to have a 
history of coronary artery disease (53% vs45%; p = 0.04). The mean total length of stay 
was 6.1 days for patients with diabetes and 4.8 days among patients without (p = 0.01). 
An adverse postoperative cardiac event (myocardial infarction, congestive heart failure, or 
arrhythmia) occurred in nine patients with diabetes (3.2%) and in five nondiabetic 
patients (1.1%; p < 0.05). By logistic regression a alysis, however, diabetes was not an 
independent risk factor for a postoperative cardiac event (p = 0.28). There were 11 
perioperative neurologic events (eight cerebrovascular accidents, three transient ischemic 
attacks) during the entire period (1.5%), of which six were among diabetic patients 
(2.1%) and five among nondiabetic patients (1.1%; p = NS). Of the eight cerebrovascular 
accidents, three occurred in diabetic patients (1.0%) and five in nondiabetic patients 
(1.1%; p = NS). The total operative mortality rate was 0.3% (diabetic patients, 1 of 284, 
0.35%; nondiabetic, 1 of 447, 0.2%). 
Conclusions: Patients with diabetes who undergo carotid endarterectomy are more likely 
to have coexisting cardiac disease, which may contribute to a higher incidence of 
postoperative cardiac morbidity. Diabetes mellitus alone, however, is not a risk factor for 
postoperative cardiac morbidity in patients who undergo carotid surgery. In addition, 
carotid endarterectomy ay be safely performed in patients with diabetes with neuro- 
logic morbidity and mortality rates that are comparable with those of the nondiabetic 
population. (J Vasc Surg 1997;25:1070-6.) 
Diabetes mellitus is found in as many as 13 mil- 
lion people nationally, or 5.2% of the U.S. popula- 
From the Division of Vascular Surgery, Department of Surgery, 
Deaconess Hospital, Harvard Medical School. 
Presented atthe Twenty-third Annual Meeting ofthe New En- 
gland Society for Vascular Surgery, Dixville Notch, N.H., Sep. 
26-27, 1996. 
Reprint requests: Frank W. LoGerfo, MD, 110 Francis St., Suite 
5B, Boston, MA 02215. 
Copyright © 1997 by The Society for Vascular Surgery and Inter- 
national Society for Cardiovascular Surgery, North American 
Chapter. 
0741-5214/97/$5.00 + 0 24/6/81464 
1070 
tion, and more than 650,000 new cases are diag- 
nosed annually? Diabetes is a major risk factor for 
stroke. The risk of stroke is at least 2.5-fold higher in 
patients who have diabetes than in nondiabetic sub- 
jects? ,3 Moreover, the mortality rate and severity of 
stroke is higher among patients with diabetes. 4-6 
Carotid endarterectomy (CEA) has been shown 
to reduce the risk of stroke in selected symptomatic 
and asymptomatic patients who have a high-grade 
internal carotid artery stenosis; however, the poten- 
tial benefit of the operation would bc eliminated with 
a postoperative morbidity and mortality rate greater 
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than 3% to 5%. 7 9 The leading causes ofperioperative 
death and disability after CEA are cardiovascular dis- 
ease and stroke. 1°,~1 Among patients who undergo 
vascular surgery, the presence of diabetes i  an inde- 
pendent risk factor for predicting operative cardiac 
death and, in addition, may increase the risk of early 
postoperative c rebral complications) 2,13 
In view of the recent beneficial results of CEA in 
the prevention of stroke, and with an increasing inci- 
dence of diabetes, it is anticipated that more patients 
with diabetes will undergo CEA. In the present 
study, we report our experience with CEA in patients 
with and without diabetes in an effort to define the 
safety of this operation in this population. 
PATIENTS AND METHODS 
Since January 1990, data from every patient who 
has undergone vascular surgery at the Deaconess 
Hospital has been prospectively entered into a com- 
puterized vascular registry. We reviewed the data on 
all consecutive patients who underwent CEA be- 
tween January 1990 and December 1995. Patients 
who underwent simultaneous cardiac or aortic arch 
procedures were excluded from this report. 
A total of 732 CEA procedures were performed 
on 684 patients; of these procedures, 284 (39%) 
were performed on patients with diabetes and 448 
(61%) on patients without diabetes. Among patients 
with diabetes, 174 (61%) were insulin dependent, 98 
(35%) were on oral hypoglycemic agents, and 12 
(4%) had controlled iets. Clinical presentation was 
classified as asymptomatic, transient ischemic attack 
(TIA; temporary focal neurologic deficits lasting no 
more than 24 hours, with complete recovery), or 
cerebrovascular ccident (CVA). Patients who had 
nonhemispheric symptoms, such as dizzy spells or 
vertigo, were classified as asymptomatic) 4 
Internal carotid artery percent stenosis was calcu- 
lated as percent diameter reduction on the preopera- 
tive arteriogram. Preoperative arteriograms were ob- 
tained in 185 patients with diabetes (65%) and 330 
nondiabetic patients (74%). I f  arteriography ad not 
been performed before surgery, the percent stenosis 
was derived from a magnetic resonance angiogram, 
according to criteria previously established by our 
vascular laboratory, specifically using two-dimen- 
sional, three-dimensional, nd source images. Arte- 
riograms or magnetic resonance angiograms were 
obtained for a total of 639 patients (87%), and the 
mean percent stenosis is reported for these patients. 
CEA was performed under either general, re- 
gional, or local anesthesia (Table I), with no differ- 
ence between the type of anesthetic among diabetic 
Table I. Type of anesthesia 
Type of Diabetic patients Nondiabetic patients 
anesthesia (n = 284) (n = 448) 
General 204 (72%) 288 (64%) 
Regional 69 (24%) 142 (32%) 
Local 11 (4%) 18 (4%) 
and nondiabetic patients. Shunting was performed 
routinely in all patients who underwent general anes- 
thesia. Patch angioplasty was used selectively on the 
basis of internal carotid artery size and routinely in all 
patients who had recurrent stenoses. 
Preoperative, postoperative, and total length of 
stay were calculated for each patient. Patients who 
underwent a concomitant procedure during the 
same admission were excluded from the length of 
stay analysis. Perioperative neurologic morbidity was 
classified as either a TIA (lasting less than 24 hours, 
full recovery) or permanent s roke (deficit present at 
time of hospital discharge). A computed tomo- 
graphic scan of the head was performed in all patients 
who had a new neurologic deficit after surgery. 
A postoperative electrocardiogram was routinely 
obtained in all patients with diabetes and selectively 
in nondiabetic patients who had a previous history of 
coronary artery disease, heart failure, or arrhythmia. 
Cardiac isoenzymes were obtained in all patients who 
had new findings on the postoperative electrocardio- 
gram. An adverse postoperative cardiac event was 
defined as postoperative myocardial infarction (MI; 
creatinine-kinase myocardial fraction of 5% or great- 
er), congestive heart failure (CHF), or new arrhyth- 
mia (rhythm other than sinus). 
Statistical analysis was performed with the 
Minitab computer program (State College, Penn.). 
Categorical variables were compared with the X 2 test, 
and continuous variables were compared with Stu- 
dent's t test. Fisher's exact test was performed for 
small expected frequencies. The preoperative vari- 
ables that were positively associated with postopera- 
tive outcome at a p value less than 0.05 were then 
selected for the multivariate analysis using binary 
logistic regression analysis. All tests are two-tailed, 
with a p value less than 0.05 considered as significant. 
RESULTS 
Patients. Demographic data, including cardiac 
and vascular history, are given in Table II. Patients 
with diabetes were younger at presentation than 
patients in the nondiabetic group, and a greater 
percentage of patients with diabetes who under- 
went CEA were female than nondiabetic patients. 
JOURNAL OF VASCULAR SURGERY 
1072 Akbari etal. lune 1997 
Table I I .  Clinical characteristics 
Diabetic Nondiabetic 
patients patients 
(n = 284) (n = 448) 
Age (yr; mean + SD) 68.8 + 8.5 70.9 -+ 8.4 <0.005 
Sex 
Male 151 (53%) 284 (63%) - -  
Female 133 (47%) 164 (37%) 0.005 
Smoking 0.93 
Current 56 (19%) 93 (21%) - -  
Former 179 (63%) 280 (62%) - -  
Never 42 (15%) 70 (16%) - -  
Unknown 7 (3%) 5 (1%) - -  
Previous vascular surgery 147 (52%) 131 (29%) <0.001 
Previous PTCA 25 (9%) 37 (8%) 0.81 
Previous CABG 73 (26%) 86 (19%) 0.04 
Hypertension 209 (74%) 313 (70%) 0.33 
CAD 151 (53%) 203 (45%) 0.04 
CHF 45 (16%) 32 (7%) <0.005 
Arrhythmia 38 (13%) 42 (9%) 0.09 
PTCA, Percutaneous transluminal coronary angioplasty; CABG, 
coronary artery bypass; CAD, coronary artery disease. 
Table I I I .  Previous vascular surgery 
Diabetic Nondiabetic 
patients patients 
(n = 284) (n = 448) 
Infrainguinal bypass 78 (27%) 23 (5%) <0.001 
Aortoiliac-femoral 25 (9%) 20 (4.5%) 0.02 
reconstruction 
AAA repair 2 (0.7%) 13 (3%) 0.04 
Upper extremity arterial 4 (1.4%) 0 (0%) 0.01 
bypass 
Contralateral CEA 43 (15%) 72 (16%) 0.73 
AAA, Abdominal ortic aneurysm. 
Coexisting coronary artery disease and a history of  
CHF were also more common in patients with 
diabetes. 
A significantly greater percentage of diabetic pa- 
tients than nondiabetic patients had undergone pre- 
vious vascular surgical procedures. As seen in Table 
I I I ,  prior infrainguinal arterial bypass grafting, aor- 
toiliac-femoral reconstruction, and upper extremity 
arterial surgery were all significantly more common 
among diabetic patients than nondiabetic patients. 
However, this difference was not seen with prior 
contralateral CEA. 
Degree o f  stenosis and indications for opera- 
tion. The mean (+SD) internal carotid artery per- 
cent stenosis was 86.6% -+ 10.6% among diabetic 
patients and 86.4% _+ 10.6% among nondiabetic pa- 
tients (p = NS). The clinical presentation of the two 
Table IV. Clinical presentation 
Diabetic Nondiabetic 
patients patients 
(n = 284) (n = 448 
Asymptomatic 128 (45%) 191 (43%) 0.52 
Stroke 46 (16%) 51 (11%) 0.06 
TIA 110 (39%) 206 (46%) 0.08 
Restenosis 12 (4%) 15 (3%) 0.54 
Asymptomatic 4 (1%) 9 (2%) 0.55 
Symptomatic 8 (3%) 6 (1%) 0.16 
Table V. Length of  stay 
Diabetic Nondiabetic 
patients patients 
(n = 284) (n = 448) 
Preoperative LOS 1.9 -+ 0.2 1.6 + 0.2 0.18 
Postoperative LOS 4.1 + 0.4 3.2 + 0.2 0.01 
Total LOS 6.1 + 0.5 4.8 _+ 0.3 0.01 
LOS, Length of stay. 
groups is given in Table IV. Among the entire co- 
hort, 319 patients (44%) were asymptomatic. There 
was no difference between diabetic patients and non- 
diabetic patients in the clinical presentation and indi- 
cations for CEA. 
Hospita l  length of  stay. Although there was no 
difference between diabetic patients and nondiabetic 
patients in the mean length of stay before CEA, 
patients with diabetes had both a significantly longer 
postoperative stay and a longer total hospital ength 
of stay compared with patients without diabetes (Ta- 
ble V). 
Perioperative cardiac morbidity.  A total of  14 
adverse cardiac events (MI, CHF,  or new arrhyth- 
mia) occurred in the total population; there were no 
concomitant procedures during the same hospital- 
ization in these 14 patients (Table VI). By univariate 
analysis, patients with diabetes were more likely to 
have an adverse postoperative cardiac event com- 
pared with the nondiabetic group (p = 0.05). This 
trend was not seen when comparing for postopera- 
tive MI alone. Other univariate correlates of an ad- 
verse postoperative cardiac event included previous 
vascular surgery, previous MI, and a history of heart 
failure. However, when these factors were entered 
into a logistic regression model, the sole clinical predic- 
tor of perioperative cardiac morbidity was a history of 
CHF (p = 0.05; odds ratio, 3.25; 95% confidence 
interval, 1.00 to 10.68). Eight postoperative cardiac 
events occurred with the patient under general anesthe- 
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postoperative cardiac event 
cardiac event (n = 718) p 
Clinical variable (n = 14) (%) (%) (Univariate) 
P 
(Multivariate) 
Previous MI 8 (57) 188 (26) 0.02 0.07 
Arrhythmia 3 (21) 77 ( l l )  0.17 - -  
Previous vascular surgery 9 (64) 269 (37) 0.05 0.12 
Diabetes 9 (64) 275 (38) 0.05 0.28 
History of CHF 5 (36) 77 (11) 0.005 0.05 
History of angina 5 (36) 152 (21) 0.20 - -  
Hypertension 10 (71) 512 (71) 0.97 - -  
sia, six with the patient under egional anesthesia, nd 
none among the patients who had a local anesthetic 
(p = NS). There were no cardiac omplications among 
the patients who underwent a concomitant procedure 
in the same hospitalization. 
Perioperative neurologic morbidity and mor- 
tality data. There were 11 perioperative n urologic 
events (eight CVAs, three TIAs) among the entire 
population (1.5%), six among patients with diabetes 
(2.1%) and five among patients without diabetes 
(1.1%; p = 0.28; Table VII). Eight perioperative 
neurologic events occurred in patients who under- 
went general anesthesia and three in patients who 
had regional anesthesia (p = NS). Of the eight 
CVAs, three occurred in patients with diabetes 
(1.0%) and five in nondiabetic patients (1.1%; p = 
0.94). Postoperative CVAs developed in two asymp- 
tomatic patients (both with diabetes), for a postoper- 
ative stroke rate of 0.27% among all asymptomatic 
patients and 0.72% for asymptomatic patients with 
diabetes. 
There were two perioperative deaths during the 
entire period (0.3%). An asymptomatic woman with 
diabetes died of an MI on the eighth postoperative 
day. The second death occurred in a nondiabetic 
man and was caused by rupture of the arteriotomy 
closure suture line. 
DISCUSSION 
The successful outcome of CEA depends on ap- 
propriate indications and patient selection, meticu- 
lous operative technique, and optimal preoperative 
and postoperative care. Preoperative identification of
patients at risk for neurologic and cardiac morbidity 
allows for appropriate attention to and changes in 
intraoperative and postoperative management. In
the current series, we have shown that CEA may be 
Table VII. Postoperative morbidity and 
mortality data for patients with and 
without diabetes 
Diabetic patients Nondiabetic patients 
(n = 284) # = 448) p 
Stroke 3 (1%) 5 (1.1%) 0.94 
TIA 3 (1%) 0 (0%) 0.03 
Death 1 (0.35%) 1 (0.2%) - -  
safely performed in patients with diabetes, a group 
that is at risk for cardiac and possibly neurologic 
complications after CEA, and our perioperative 
stroke and mortality rates compare favorably with 
other series. 79 
Although we could not find a higher postopera- 
tive neurologic morbidity rate among patients who 
have diabetes, everal reports have noted a different 
postoperative course in this population. Skydell et 
al. ta reported on the incidence of hypertension after 
CEA, which is associated with an increased incidence 
ofneurologic complications, and found that diabetes 
mellitus was the single most common variable that 
was associated with this entity. They postulated that 
diabetes may reduce the threshold for loss of cerebral 
autoregulation a d thus lead to a positive-feedback 
hypertensive cycle. At our institution, we have main- 
tained an aggressive pharmacologic approach toward 
treating postoperative hypertension in these patients. 
Salenius et al. t3 reported that type II diabetes melli- 
ms was a risk factor for postoperative stroke. In their 
series, eight of 40 patients who had diabetes also had 
a postoperative stroke, in contrast to 24 strokes in 
the 291 patients without diabetes. However, criti- 
cism may be leveled at the high overall postoperative 
stroke rate of 9.6% and at the early time period of the 
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study (1965 to 1984), factors that limit the exten- 
sion of the conclusions to current practice. 
More recently, Riies et al. 16 examined both pa- 
tient risk factors and technical factors in an analysis of 
the causes ofperioperative stroke in 3062 CEA pro- 
cedures. Although patients with diabetes had a 3.6% 
incidence (17 of 467) of postoperative stroke com- 
pared with a 2.2% incidence (66 of 3062) for the 
entire population, the authors emphasized that tech- 
nical error was the most common cause of postoper- 
ative stroke, even in the high-risk subgroups, who are 
particularly less tolerant to technical mishaps. In- 
creasing evidence has accumulated that shows a 
greater incidence of brain damage after ischemia jr
and altered brain glucose metabolism and blood 
flow ~s in experimental diabetes. These factors may 
place the patient with diabetes at even greater risk for 
postoperative neurologic morbidity from any isch- 
emic insult, most of which, as noted by Riles et al., 
are related to intraoperative technical problems. 
Therefore, a low postoperative stroke rate among 
patients with diabetes may be expected if the overall 
postoperative stroke rate is low, which in turn is a 
reflection of surgeon-dependent technical adequacy. 
In our series, patients with diabetes were more 
likely to have an adverse postoperative cardiac event 
than were nondiabetic patients. However, it is note- 
worthy that patients with diabetes in our series were 
also more likely to have a preoperative history of 
coronary artery disease and CHF, factors that may 
have contributed to a higher cardiac morbidity rate 
in these patients. In fact, our multivariate analysis 
failed to identify diabetes alone as a cardiac risk fac- 
tor, thus further supporting the theory that patients 
with diabetes are more prone to postoperative car- 
diac morbidity because of a higher incidence of pre- 
existing cardiac disease. 
Among patients who undergo vascular surgery, 
Eagle et al. 12 identified the presence of diabetes as 
one of five independent correlates of postoperative 
cardiac events, which were defined as acute MI, pul- 
monary edema, unstable angina, or cardiac death. 
They also found that patients with diabetes were 2.6 
times more likely to have one of these adverse out- 
comes. In contrast to the present study, however, the 
study by Eagle et al. was performed with patients 
who underwent all types of vascular surgery and not 
just CEA alone. More recently, Ombrellaro et al. 19 
reported on 266 patients who underwent CEA and 
noted an adverse cardiac event (MI, CHF,  angina, or 
new dysrhythmia) in 38 patients (14.3%). Among 62 
patients with diabetes, one or more of these events 
occurred in 14%, compared with a 16% incidence in 
nondiabetic patients, adifference that was not signif- 
icant. 
We also found a longer postoperative l ngth of 
stay and a longer total hospital ength of stay among 
patients with diabetes. Although it is likely that the 
higher incidence of postoperative cardiac events in 
this group contributed to this finding, our experi- 
ence with infrainguinal bypass surgery in patients 
with diabetes 2° has made us more aware of the po- 
tential for cardiac morbidity. Recognizing that silent 
myocardial ischemia is more likely to develop in pa- 
tients with diabetes, 21 postoperative cardiac moni- 
toring is maintained on these patients, particularly in 
those who have a preoperative history of coronary 
artery disease or CHF. 
Our study has several limitations. As a retrospec- 
tive study, it is impossible to have a completely stan- 
dardized protocol for stratifying patients; moreover, 
unrecognized confounding variables may have been 
introduced in this retrospective r view. Finally, the 
time period of the present study (1990 to 1995) has 
been a period of tremendous change in the preoper- 
ative care (e.g., decreasing use of arteriography), 
length of stay (decreasing hospital and intensive care 
unit length of stay), and selection of patients who 
undergo CEA. 22 These changes should be consid- 
ered when interpreting the results of the present 
study. 
CONCLUSION 
We have found that CEA may be safely per- 
formed in patients with diabetes. In view of the fact 
that diabetes mellitus is the strongest independent 
risk factor for death from stroke, 6it is hoped that our 
findings will increase an awareness of the appropriate 
role of CEA in reducing stroke risk in this popula- 
tion. 
REFERENCES 
1. American Diabetes Association. Diabetes: 1993 Vital Statis- 
tics. 1993. 
2. Kannel WB, McGee DL. Diabetes and cardiovascular disease: 
the Framingham Study. JAMA 1979;241:2035-8. 
3. Stokes J, Kannel WB, WolfPA, Cupples LA, D'Agostino RB. 
The relative importance of selected risk factors for various 
manifestations of cardiovascular disease among men and 
women from 35 to 64 years old: 30 years of follow-up in the 
Framingham Study. Circulation 1987;75:65-73. 
4. Alex M, Baron EK, Goldenberg S,Blumenthal HT. An au- 
topsy study of cerebrovascular accident in diabetes mellitus. 
Circulation 1962;25:666-73. 
5. Mortel KP, Meyer JS, Sims PA, McClintic K. Diabetes melli- 
ms as a risk factor for stroke. South Med J 1990;83:904-11. 
6. Tuomilehto J, Rastenyte D, Jousilahti P, Sarti C, Vartiainen 
E. Diabetes mellitus as a risk factor for death from stroke: 
JOURNAL OF VASCULAR SURGERY 
Volume 25, Number 6 Akbar i  et al. 1075 
prospective study of the middle-aged Finnish population. 
Stroke 1996;27:210-5. 
7. Moore WS, Barnett HJ, Beebe t-IG, Bernstein EF, Brener BJ. 
Guidelines for carotid endarterectomy: a multidisciplinary 
consensus statement from the ad hoc committee, American 
Heart Association. Stroke 1995;26:188-201. 
8. North American Symptomatic Carotid Endarterectomy Trial 
Collaborators. Beneficial effect of carotid endarterectomy in 
symptomatic patients with high-grade carotid stenosis. 
N Engl J Med 1991;325:44543. 
9. Executive Committee for the Asymptomatic Carotid Athero- 
sclerosis Study. Endarterectomy forasymptomatic carotid ar- 
tery stenosis, lAMA 1995;273:1421-8. 
10. L'Italien GJ, Cambria RP, Cutler BS, Leppo JA, Paul SD, 
Brewster DC, et al. Comparative early and late cardiac mor- 
bidity among patients requiring different vascular surgery pro- 
cedures. J Vasc Surg 1995;21:935-44. 
11. Mackey WC, O'Donnell TF lr, Callow AD. Cardiac risk in 
patients undergoing carotid endarterectomy: impact on peri- 
operative and long-term ortality. J Vasc Surg 1990;1I :226- 
34. 
12. Eagle KA, Coley CM, Newell JB, et al. Combining clinical 
and thallium data optimizes preoperative assessment of car- 
diac risk before major vascular surgery. Ann Intern Med 
1989;110:859-66. 
13. Salenius JP, Harju E, Riekkinen H. Early cerebral complica- 
tions in carotid endarterectomy: risk factors. J Cardiovasc 
Surg (Torino) 1990:31:162-7. 
14. Beebe HG, Clagett PC, DeWeese JA, et al. Assessing risk 
associated with carotid endarterectomy: a statement for 
health professionals by an ad hoc committee on carotid sur- 
gery standards of the Stroke Council, American Heart Asso- 
ciation. Stroke 1989;20:314-5. 
15. Skydell JL, Machleder HI, Baker JD, Busuttil RW, Moore 
WS. Incidence and mechanism of post-carotid endarterec- 
tomy hypertension. Arch Surg 1987;122:1153-5. 
16. Riles TS, Imparato AM, Jacobowitz GR, Lamparello PJ, Gi- 
angola G, Adelman MA, Landis R. The cause ofperioperative 
stroke after carotid endarterectomy. J Vasc Surg 1994;19: 
206-16. 
17. Pulsinelli WA, Waldman S, Rawlinson D, Plum F. Moderate 
hyperglycemia augments i chemic brain damage: a neuro 
pathologic study in the rat. Neurology 1982;32:1239-46. 
18. McCall AL. Cerebral microvascular transport and metabolism: 
implications for diabetes. In: Ruflerman N, Williamson J, 
Brownlee M, editors. Hyperglycemia, diabetes, and vascular dis- 
ease. 1st ed. New York: Oxford University Press, 1992:59-103. 
19. Ombrellaro MP, Dieter RA III, Freeman M, Stevens SL, 
Goldman MH. Role ofdipyridamole myocardial scintigraphy 
in carotid artery surgery. J Am Coil Surg 1995;181:451-8. 
20. LoGerfo FW, Gibbons GW, Pomposelli FB Jr, et al. Trends in 
the care of the diabetic foot: expanded role of arterial recon- 
struction. Arch Surg 1992;127:617-21. 
21. Nesto RW, Watson FS, Kowalchuk GJ, et al. Silent myocar- 
dial ischemia nd infarction in diabetics with peripheral vascu- 
lar disease: assessment by dipyridamole thallium-201 scintig- 
raphy. Am Heart J 1990;120:1073~7. 
22. Hirko MK, Morasch MD, Burke K, Greisler HP, Littooy FN, 
Baker WH. The changing face of carotid endarterectomy. J 
Vasc Surg 1996;23:622-7. 
Submitted Oct. 3, 1996; accepted Feb. 19, 1997. 
DISCUSSION 
Dr. K. Craig Kent  (Boston, Mass.). These days we, 
and I 'm sure you likewise, are sending many of your pa- 
tients home on the first postoperative day after CEA. How- 
ever, I saw in your results the difference of 3 and 4 days for 
the length of stay for patients with diabetes and nondia- 
betic patients. What do you do now? For patients with 
diabetes, should we keep them longer? Should they stay 2 
days, or do most of the complications occur early? If a 
diabetic patient does well, can he in fact be sent home on 
the first postoperative day? 
Dr. Cameron M. Akbari.  Actually, we looked at our 
length of stay in the more recent years, in 1994 and 1995 
as this increasing trend toward decreasing the length of the 
stay has happened, and in fact we still find a significant 
difference. The mean is about 2.7 days for nondiabetic 
patients who undergo CEA, and it's a little bit over 3 days 
for patients with diabetes. All of this translates into the fact 
that perhaps one reason why the length of stay is higher in 
these patients is because we are more closely attuned to the 
fact that they may have postoperative cardiac dysfunction and 
we have seen this in our lower extremity arterial bypass pa- 
tients. We are less likely, for instance, to send these patients 
straight out to the surgical ward on the first postoperative day 
because many of these patients are monitored from a cardiac 
standpoint for longer periods. 
Dr. IL Clement Dar l ing I I I  (Albany, N.Y.). That was 
an excellent presentation with superb results in a very 
difficult patient population. I just have a couple of ques- 
tions. Was there any difference in your length of stay in the 
patients with diabetes who underwent cervical block anes- 
thesia compared with general anesthesia? Were there any 
differences in the cardiac events in those two patient popu- 
lations? 
Dr. Akbari.  We did not specifically look at the differ- 
ences in length of stay between the patients who had 
cervical block anesthesia nd those who had the general 
anesthetic, so I cannot answer that question. 
In regard to your second question, we have repeatedly 
looked at the incidence of cardiac morbidity in our patients 
who undergo general, regional, and local anesthesia, nd 
there has been no difference in outcome in those patients 
when undergoing CEA. Similarly, there has been no differ- 
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ence in the incidence of neurologic morbidity in those 
patients. 
Dr. Jack L. Cronenwett (Lebanon, N.H.). Were you 
able to try to separate the effects of preoperative cardiac risk 
factors and diabetes? That is, did you use multivariate 
analysis to determine whether diabetes was an independent 
risk factor or just a marker for these cardiac risks? In other 
words, if you had a patient with diabetes who had no 
cardiac risk factors identified before surgery, would that 
patient have a heightened risk for carotid surgery? 
Dr. Akbari. I think that is a really interesting question. 
We know that diabetes in a previous logistic regression 
analysis, that is, from the group at Massachusetts Gen- 
eral, has been identified as an independent risk factor for 
postoperative cardiac morbidity. Unfortunately, that 
trial, as you may well know, is retrospective as well. We 
specifically cannot exclude the fact that patients with 
diabetes do have more underlying cardiac disease even 
with a normal electrocardiogram and no history of car- 
diac abnormalities. 
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